SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Stock Price, Forecast & Analysis

FRA:1SXP • DE000A3ENQ51

14.82 EUR
-0.44 (-2.88%)
Last: Feb 23, 2026, 05:29 PM

1SXP.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap2.23B
Revenue(TTM)996.56M
Net Income(TTM)150.74M
Shares150.61M
Float34.64M
52 Week High30.25
52 Week Low13.76
Yearly Dividend0.16
Dividend Yield1.19%
EPS(TTM)0.97
PE15.28
Fwd PE13.07
Earnings (Next)05-13
IPO2023-09-28
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
1SXP.DE short term performance overview.The bars show the price performance of 1SXP.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30

1SXP.DE long term performance overview.The bars show the price performance of 1SXP.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of 1SXP.DE is 14.82 EUR. In the past month the price increased by 1.6%. In the past year, price decreased by -35.61%.

SCHOTT PHARMA AG& CO KGAA / 1SXP Daily stock chart

1SXP.DE Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to 1SXP.DE. When comparing the yearly performance of all stocks, 1SXP.DE is a bad performer in the overall market: 92.43% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
1SXP.DE Full Technical Analysis Report

1SXP.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to 1SXP.DE. While 1SXP.DE has a great profitability rating, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
1SXP.DE Full Fundamental Analysis Report

1SXP.DE Financial Highlights

Over the last trailing twelve months 1SXP.DE reported a non-GAAP Earnings per Share(EPS) of 0.97. The EPS decreased by -2.02% compared to the year before.


Industry RankSector Rank
PM (TTM) 15.13%
ROA 9.26%
ROE 16.21%
Debt/Equity 0.08
Chartmill High Growth Momentum
EPS Q2Q%15.79%
Sales Q2Q%4.5%
EPS 1Y (TTM)-2.02%
Revenue 1Y (TTM)4.39%
1SXP.DE financials

1SXP.DE Forecast & Estimates

19 analysts have analysed 1SXP.DE and the average price target is 20.16 EUR. This implies a price increase of 36.01% is expected in the next year compared to the current price of 14.82.

For the next year, analysts expect an EPS growth of 2.98% and a revenue growth 2.19% for 1SXP.DE


Analysts
Analysts75.79
Price Target20.16 (36.03%)
EPS Next Y2.98%
Revenue Next Year2.19%
1SXP.DE Analyst Estimates1SXP.DE Analyst Ratings

1SXP.DE Ownership

Ownership
Inst Owners22.72%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
1SXP.DE Ownership

1SXP.DE Competitors/Peers

The largest stocks on the EU markets in the "Life Sciences Tools & Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
SRT3 SARTORIUS AG-VORZUG37.7317.896B
DIM SARTORIUS STEDIM BIOTECH33.1117.787B
56S1 SARTORIUS STEDIM BIOTECH33.9417.626B
SRT SARTORIUS AG30.5414.766B
QIA QIAGEN N.V.17.658.443B
EVT EVOTEC SE N/A2.168B
GXI GERRESHEIMER AG6.35705.998M
FF FINE FOODS & PHARMACEUTICALS16.17254.242M
ALECR EUROFINS CEREP-REGR N/A174M

About 1SXP.DE

Company Profile

1SXP logo image SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,811 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.

Company Info

SCHOTT PHARMA AG& CO KGAA

Hattenbergstrasse 10

MAINZ HESSEN DE

Employees: 4775

1SXP Company Website

1SXP Investor Relations

Phone: 496131660

SCHOTT PHARMA AG& CO KGAA / 1SXP.DE FAQ

Can you describe the business of SCHOTT PHARMA AG& CO KGAA?

SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,811 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.


What is the current price of 1SXP stock?

The current stock price of 1SXP.DE is 14.82 EUR. The price decreased by -2.88% in the last trading session.


Does SCHOTT PHARMA AG& CO KGAA pay dividends?

SCHOTT PHARMA AG& CO KGAA (1SXP.DE) has a dividend yield of 1.19%. The yearly dividend amount is currently 0.16.


What is the ChartMill rating of SCHOTT PHARMA AG& CO KGAA stock?

1SXP.DE has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Would investing in SCHOTT PHARMA AG& CO KGAA be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1SXP.DE.


What is the employee count for 1SXP stock?

SCHOTT PHARMA AG& CO KGAA (1SXP.DE) currently has 4775 employees.